Restaurants and gyms drove COVID-19 transmission this spring
Restaurants, cafes, and gyms acted as “superspreading” sites for COVID-19 transmission last spring, accounting for the majority of new infections […]
Self-reports of smell and taste changes provide earlier markers of the spread of infection of SARS-CoV-2 than current governmental indicators, […] DR ELLIE CANNON: Families bombarded with pointless calls, bullying and threats… and worst of all, Test and Trace is failing. […] An evolving understanding of cancer that incorporates the physical properties of tumors and their surrounding tissues into existing biologic and […] Researchers at Ruhr-Universität Bochum (RUB) have studied the role of the immune response in the development of glaucoma in mice. […] Found tethered in a locked car on a scorching 96-degree day in New York City, Shiva and three other puppies […] The COVID-19 pandemic has reignited interest in wastewater surveillance, where sewage systems are monitored for the presence of viruses, bacteria […] With the holidays approaching, many people are considering whether to visit relatives or friends in the coming weeks. At the […] Numerous studies over the last few weeks have pointed out that the effects of the Corona pandemic on people’s mental […] 21 October 2020 — ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi […]and
Smell and taste changes provide early indication of COVID-19 community spread
DR ELLIE CANNON: How did Test and Trace turn into such a fiasco?
Melding biology and physical sciences yields deeper understanding of cancer
The link between glaucoma, the immune system and protein tenascin-C
From Abandoned to Elated, Shiva Finds Her Home and Happiness
Sewage surveillance: How scientists track and identify diseases like COVID-19 before they spread
How to use COVID-19 testing and quarantining to safely travel for the holidays
COVID-19 study: Meaning in life and self-control protect against stress
ViiV Healthcare Announces Analysis Showing no Antiretroviral Therapy Interruptions Due to COVID-19 Across its Clinical Development Programme for Investigational, Long-Acting Cabotegravir and Rilpivirine